Yang et al. anchored CD30-specific aptamers to the cell surface to generate aptamer-engineered NK cells (ApEn-NK), and targeted NK cells guided by aptamers triggered higher apoptosis/mortality in lymphoma cells, thus providing a promising new approach for NK cell-targeted immunotherapy [146]. Here, TNFRSF8 is linked to lymphoma.